|
|
|
|
|
Inactive Indication- |
Drug Highest PhasePhase 1 |
First Approval Ctry. / Loc.- |
First Approval Date- |
A Phase I Clinical Study to Evaluate the Mass Balance of [14C]SIM0270 in Healthy Chinese Adult Subjects
This is a single-center, non-randomized, open-label, single-cohort, single-dose phase I clinical study in healthy Chinese adult male subjects.
100 Clinical Results associated with Jiangsu Xiansheng Zaiming Pharmaceutical Co., Ltd
0 Patents (Medical) associated with Jiangsu Xiansheng Zaiming Pharmaceutical Co., Ltd
100 Deals associated with Jiangsu Xiansheng Zaiming Pharmaceutical Co., Ltd
100 Translational Medicine associated with Jiangsu Xiansheng Zaiming Pharmaceutical Co., Ltd